Baby Safety / Compounds / N,N-Dimethyltryptamine (DMT)

Is N,N-Dimethyltryptamine (DMT) safe for babies and kids?

Very high risk for kids

Infants are more vulnerable to N,N-Dimethyltryptamine (DMT) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is n,n-dimethyltryptamine (dmt)?

The IUPAC name is 2-(1H-indol-3-yl)-N,N-dimethylethanamine.

Also known as: N,N-DIMETHYLTRYPTAMINE, DIMETHYLTRYPTAMINE, 2-(3-Indolyl)ethyldimethylamine, 3-(2-Dimethylaminoethyl)indole.

IUPAC name
2-(1H-indol-3-yl)-N,N-dimethylethanamine
CAS number
61-50-7
Molecular formula
C12H16N2
Molecular weight
188.27 g/mol
SMILES
CN(C)CCc1c[nH]c2ccccc12
PubChem CID
6089

Risk for babies

Very high risk

Infants are more vulnerable to N,N-Dimethyltryptamine (DMT) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of N,N-Dimethyltryptamine (DMT), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

2 regulatory and scientific bodies have classified N,N-Dimethyltryptamine (DMT). The classifications differ — that's the data.

AgencyYearClassificationNotes
DEA1971Schedule I controlled substance
UN19711971 Convention — Schedule I (DMT itself; ayahuasca plants not scheduled)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter n,n-dimethyltryptamine (dmt)

  • Natural Product
  • Illicit Drug

Safer alternatives

Lower-risk approaches that achieve a similar outcome to N,N-Dimethyltryptamine (DMT):

  • Ketamine (FDA-approved for depression)
    Trade-offs: Different mechanism (NMDA antagonist). FDA-approved (esketamine/Spravato). Dissociative rather than psychedelic. Abuse potential.
    Relative cost: $600-900/treatment session

Frequently asked questions

Is n,n-dimethyltryptamine (dmt) safe for kids?

Infants are more vulnerable to N,N-Dimethyltryptamine (DMT) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What should I do if my child is exposed to n,n-dimethyltryptamine (dmt)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See N,N-Dimethyltryptamine (DMT) in the baby app

Look up products containing n,n-dimethyltryptamine (dmt), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →